|
1
|
Woodman RJ, Chew GT and Watts GF:
Mechanisms, significance and treatment of vascular dysfunction in
type 2 diabetes mellitus: Focus on lipid-regulating therapy. Drugs.
65:31–74. 2005. View Article : Google Scholar
|
|
2
|
Terasaka N, Wang N, Yvan-Charvet L and
Tall AR: High-density lipoprotein protects macrophages from
oxidized low-density lipo-protein-induced apoptosis by promoting
efflux of 7-ketocholesterol via ABCG1. Proc Natl Acad Sci USA.
104:15093–15098. 2007. View Article : Google Scholar
|
|
3
|
Tauber JP, Cheng J and Gospodarowicz D:
Effect of high and low density lipoproteins on proliferation of
cultured bovine vascular endothelial cells. J Clin Invest.
66:696–708. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tauber JP, Cheng J, Massoglia S and
Gospodarowicz D: High density lipoproteins and the growth of
vascular endothelial cells in serum-free medium. In Vitro.
17:519–530. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tamagaki T, Sawada S, Imamura H, Tada Y,
Yamasaki S, Toratani A, Sato T, Komatsu S, Akamatsu N, Yamagami M,
et al: Effects of high-density lipoproteins on intracellular pH and
proliferation of human vascular endothelial cells. Atherosclerosis.
123:73–82. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sugano M, Tsuchida K and Makino N:
High-density lipoproteins protect endothelial cells from tumor
necrosis factor-alpha-induced apoptosis. Biochem Biophys Res
Commun. 272:872–876. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng L, Settle M, Brubaker G, Schmitt D,
Hazen SL, Smith JD and Kinter M: Localization of nitration and
chlorination sites on apolipoprotein A-I catalyzed by
myeloperoxidase in human atheroma and associated oxidative
impairment in ABCA1-dependent cholesterol efflux from macrophages.
J Biol Chem. 280:38–47. 2005. View Article : Google Scholar
|
|
8
|
Nobecourt E, Jacqueminet S, Hansel B,
Chantepie S, Grimaldi A, Chapman MJ and Kontush A: Defective
antioxidative activity of small dense HDL3 particles in type 2
diabetes: Relationship to elevated oxidative stress and
hyperglycaemia. Diabetologia. 48:529–538. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sorrentino SA, Besler C, Rohrer L, Meyer
M, Heinrich K, Bahlmann FH, Mueller M, Horváth T, Doerries C,
Heinemann M, et al: Endothelial-vasoprotective effects of
high-density lipoprotein are impaired in patients with type 2
diabetes mellitus but are improved after extended-release niacin
therapy. Circulation. 121:110–122. 2010. View Article : Google Scholar
|
|
10
|
Pan B, Ma Y, Ren H, He Y, Wang Y, Lv X,
Liu D, Ji L, Yu B, Wang Y, et al: Diabetic HDL is dysfunctional in
stimulating endothelial cell migration and proliferation due to
down regulation of SR-BI expression. PLoS One. 7:e485302012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lüscher TF, Landmesser U, von Eckardstein
A and Fogelman AM: High-density lipoprotein: Vascular protective
effects, dysfunction, and potential as therapeutic target. Circ
Res. 14:171–182. 2014. View Article : Google Scholar
|
|
12
|
Rader DJ: Molecular regulation of HDL
metabolism and function: Implications for novel therapies. J Clin
Invest. 116:3090–3100. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yvan-Charvet L, Matsuura F, Wang N,
Bamberger MJ, Nguyen T, Rinninger F, Jiang XC, Shear CL and Tall
AR: Inhibition of cholesteryl ester transfer protein by torcetrapib
modestly increases macrophage cholesterol efflux to HDL.
Arterioscler Thromb Vasc Biol. 27:1132–1138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen C, Venketasubramanian N, Gan RN,
Lambert C, Picard D, Chan BP, Chan E, Bousser MG and Xuemin S:
Danqi Piantang Jiaonang (DJ), a traditional Chinese medicine, in
poststroke recovery. Stroke. 40:859–863. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang H, Wang WR, Lin R, Zhang JY, Ji QL,
Lin QQ and Yang LN: Buyang Huanwu decoction ameliorates coronary
heart disease with Qi deficiency and blood stasis syndrome by
reducing CRP and CD40 in rats. J Ethnopharmacol. 130:98–102. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen DK, Zhang HQ and Zhang JH:
Intervening effect of naoxintong on anti-platelet treatment with
aspirin. Zhongguo Zhong Xi Yi Jie He Za Zhi. 28:843–846. 2008.In
Chinese. PubMed/NCBI
|
|
17
|
Grundy SM, Cleeman JI, Daniels SR, Donato
KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith
SC Jr, et al: Diagnosis and management of the metabolic syndrome:
An American heart association/national heart, lung and blood
institute scientific statement. Circulation. 112:2735–2752. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alberti KG, Zimmet P and Shaw J; IDF
Epidemiology Task Force Consensus Group: The metabolic syndrome-a
new worldwide definition. Lancet. 366:1059–1062. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang B, Li G, Guo YF, Wang SS, Liu F, Xu
HY and Yang HJ: Study on absorption location of four components
from Naoxintong capsule. Zhongguo Zhong Yao Za Zhi. 38:889–893.
2013.PubMed/NCBI
|
|
20
|
Songsong W, Haiyu X, Yan M, Xuguang W,
Yang S, Bin H, Shihuan T, Yi Z, Defeng L, Rixin L, et al:
Characterization and rapid identification of chemical constituents
of NaoXinTong capsules by UHPLC-linear ion trap/Orbitrap mass
spectrometry. J Pharm Biomed Anal. 111:104–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chung BH, Wilkinson T, Geer JC and Segrest
JP: Preparative and quantitative isolation of plasma lipoproteins:
Rapid, single discontinuous density gradient ultracentrifugation in
a vertical rotor. J Lipid Res. 21:284–291. 1980.PubMed/NCBI
|
|
22
|
Jaffe EA, Nachman RL, Becker CG and Minick
CR: Culture of human endothelial cells derived from umbilical
veins. Identification by morphologic and immunologic criteria. J
Clin Invest. 52:2745–2756. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miura S, Fujino M, Matsuo Y, Kawamura A,
Tanigawa H, Nishikawa H and Saku K: High density
lipoprotein-induced angiogenesis requires the activation of Ras/MAP
kinase in human coronary artery endothelial cells. Arterioscler
Thromb Vasc Biol. 23:802–808. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Katakami N, Kaneto H and Shimomura I:
Carotid ultrasonography: A potent tool for better clinical practice
in diagnosis of atherosclerosis in diabetic patients. J Diabetes
Investig. 5:3–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Seetharam D, Mineo C, Gormley AK, Gibson
LL, Vongpatanasin W, Chambliss KL, Hahner LD, Cummings ML, Kitchens
RL, Marce YL, et al: High-density lipoprotein promotes endothelial
cell migration and reendothelialization via scavenger receptor-B
type I. Circ Res. 98:63–72. 2006. View Article : Google Scholar
|
|
26
|
Zhu W, Saddar S, Seetharam D, Chambliss
KL, Longoria C, Silver DL, Yuhanna IS, Shaul PW and Mineo C: The
scavenger receptor class B type I adaptor protein PDZK1 maintains
endothelial monolayer integrity. Circ Res. 102:480–487. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ansell BJ, Navab M, Hama S, Kamranpour N,
Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST and
Fogelman AM: Inflammatory/antiinflammatory properties of
high-density lipoprotein distinguish patients from control subjects
better than high-density lipoprotein cholesterol levels and are
favorably affected by simvastatin treatment. Circulation.
108:2751–2756. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan B, Yu B, Ren H, Willard B, Pan L, Zu
L, Shen X, Ma Y, Li X, Niu C, et al: High-density lipoprotein
nitration and chlorination catalyzed by myeloperoxidase impair its
effect of promoting endothelial repair. Free Radic Biol Med.
60:272–281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Persegol L, Verges B, Foissac M, Gambert P
and Duvillard L: Inability of HDL from type 2 diabetic patients to
counteract the inhibitory effect of oxidised LDL on
endothelium-dependent vasorelaxation. Diabetologia. 49:1380–1386.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Biesbroeck RC, Albers JJ, Wahl PW,
Weinberg CR, Bassett ML and Bierman EL: Abnormal composition of
high-density lipoproteins in non-insulin-dependent diabetics.
Diabetes. 31:126–131. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Taskinen MR: Quantitative and qualitative
lipoprotein abnormalities in diabetes mellitus. Diabetes. 41(Suppl
2): S12–S17. 1992. View Article : Google Scholar
|
|
32
|
Nobécourt E, Zeng J, Davies MJ, Brown BE,
Yadav S, Barter PJ and Rye KA: Effects of cross-link breakers,
glycation inhibitors and insulin sensitisers on HDL function and
the non-enzymatic glycation of apolipoprotein A-I. Diabetologia.
51:1008–1017. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tong X, Lv P, Mathew AV, Liu D, Niu C,
Wang Y, Ji L, Li J, Fu Z, Pan B, et al: The compensatory enrichment
of sphingosine -1-phosphate harbored on glycated high-density
lipoprotein restores endothelial protective function in type 2
diabetes mellitus. Cardiovasc Diabetol. 13:822014. View Article : Google Scholar
|
|
34
|
Hai-Yan Z, Yong-Hong G, Zhi-Yao W, Bing X,
Ai-Ming W, Yan-Wei X, Bei L, Li-Xia and Li-Xin C: Astragalus
polysaccharide suppresses the expression of adhesion molecules
through the regulation of the p38 MAPK signaling pathway in human
cardiac microvascular endothelial cells after ischemia-reperfusion
injury. Evid Based Complement Alternat Med. 2013:2804932013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chan JY, Koon JC, Leung PC, Che CT and
Fung KP: Suppression of low-density lipoprotein oxidation, vascular
smooth muscle cell proliferation and migration by a herbal extract
of Radix Astragali, Radix Codonopsis and Cortex Lycii. BMC
Complement Altern Med. 11:322011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao J, Zhu H, Wang S, Ma X, Liu X, Wang
C, Zhao H, Fan S, Jin X, Zhao B, et al: Naoxintong protects against
atherosclerosis through lipid-lowering and inhibiting maturation of
dendritic cells in LDL receptor knockout mice fed a high-fat diet.
Curr Pharm Des. 19:5891–5896. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shin HY, Shin TY, An NH, Kim HR, Chae HJ,
Kim YK, Um JY, Hong SH and Kim HM: The immunosuppressive effect of
Buchang-tang through inhibition of mitogen-activated protein kinase
and nuclear factor activation in MOLT-4 cells. J Ethnopharmacol.
102:95–101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen H, Yu G, Sun H, Wu X and Wang H:
Comparison of adjunctive naoxintong versus clopidogrel in
volunteers with the CYP2C19*2 gene mutation accompanied with qi
deficiency and blood stasis constitution. Evid Based Complement
Alternat Med. 2011:2070342011. View Article : Google Scholar
|
|
39
|
Chen H, Zhang Y, Wu X, Li C and Wang H: In
Vitro assessment of cytochrome P450 2C19 potential of naoxintong.
Evid Based Complement Alternat Med. 2012:4302622012. View Article : Google Scholar : PubMed/NCBI
|
